Position
Squarepoint Ops LLC in Cartesian Therapeutics, Inc.
Back to the book · All holders of RNAC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$19.3K$7.21 → $6.15
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 18.2K | $131.3K | — | — | — | 0.0% |
| Q1 2026 | 2.24M | $13.8M | $6.15 | −$19.3K | $13.7M | 0.0% |